Oncoclínicas Board Calls Oct. 26 Shareholder Meeting on Suspending Josephina III’s Rights

• Oncoclínicas’ board voted 4-3 at its Sept. 23, 2026, meeting to convene an extraordinary shareholders’ meeting requested by Latache funds.
• The shareholders’ meeting was set for Oct. 26 to consider suspending the rights of Josephina III Fundo de Investimento em Participações.
• Directors unanimously authorized immediate disclosure of Latache’s request and the board’s decision through a material fact notice.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.